An Eventful Year for Nanoview Biosciences!

This year Nanoview has been present at some significant events that have taken place in both the U.S. and Europe.

Early in the year we exhibited our ExoView platform at the German Society for Extracellular Vesicles event in Frankfurt, 1st and 2nd March. The GSEV's aim is to promote research into extracellular vesicles, particularly with the goal of supporting young academics. Naturally we were delighted to attend this most important first annual meeting.

Nanoview joined fellow scientists and researchers for the ISEV workshop 'Membranes and Extracellular Vesicles' on March 24th and 25th. This highly interesting and informative roundtable event covered the following topics: EV transfer: function and functional assays, fission and secretion, update and fusion and also discussed technologies to target EV membranes and membrane proteins.

Following this, Nanoview's own Dr George Daaboul presented our technology for label free, purification free characterisation of EVs to audiences at the Circulating Biomarkers World Congress, Boston, USA. A gathering together of academic researchers as well as industry participants representing the most up-to-date technologies and advances in the expanding and evolving field of biomarkers. Our own coverage at this conference focused on the various classes of circulating biomarkers and their emerging applications: Extracellular Vesicles: Exosomes and Microvesicles Circulating Nucleic Acids.

Once more to Europe for the International Society of Extracellular Vesicles meeting, Barcelona, Spain, between 2nd and 6th May. NanoView Biosciences exhibited the ExoView platform at the 1000-strong event. A particular highlight was listening to Kai Harkonen presenting NanoView data showing how NanoView technology can be used to measure CD44 positive EVs without purification; this data, an extract from his research on CD44 as a novel homing receptor for EVs.

Colorado was the summer setting for the Keystone Symposia - Exosomes/Microvesicles: Heterogeneity, Biogenesis, Function and Therapeutic Developments, over a four day period beginning June 4th. We attended the many conferences events and talks that had an overall aim of expanding understanding of the functional and structural complexities of EVs and were proud to be one of the exhibitors there.

Finally, the Netherlands was the host to the Select Biosciences Exosomes and Liquid Biopsies Europe 2018 Conference in held in Rotterdam in October. Our president and COO Dr George Daaboul presenting once again. This exhibition brought together companies from around the world focusing on developing technologies, tools, products and services serving the liquid biopsy field. Audiences attending this event were gathered with the primary goal of bringing together the most up-to-date information and evaluating current state-of-the-field.

Now we look forward and eagerly await what 2019 will bring in this fascinating and exciting scientific arena!

NanoView Biosciences